Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Schein

Showing results (181-190 of 218) with videos related to

Pageof 22
Sort By:
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Cancer Treatment Reports|October 1, 1980
Nephrotoxicity of cis-diamminedichloroplatinum(II) as measured by urinary beta-glucuronidaseJ A Kuhn, W P Argy, T A Rakowski, et al.
Cancer Treatment Reports|November 1, 1981
Phase II study of PCNU in colorectal carcinomaE P Mitchell, J Y Killen, F P Smith, et al.
Gynecologic Oncology|December 1, 1974
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideR C Young, G P Canellos, B A Chabner, et al.
Cancer Research|May 1, 1980
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracilB Ardalan, D A Cooney, H N Jayaram, et al.
Cancer|May 15, 1983
The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancerC Gisselbrecht, F P Smith, J S MacDonald, et al.
Cancer|October 1, 1980
A phase II study of chlorozotocin in metastatic malignant melanomaD F Hoth, P S Schein, S Winokur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracilP V Woolley, M J Ayoob, F P Smith, et al.
Annals of Internal Medicine|June 1, 1974
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studiesR L Edelson, C H Kirkpatrick, E M Shevach, et al.
Cancer Chemotherapy Reports|September 1, 1973
High-dose intermittent intravenous infusion of procarbazine (NSC-77213)B A Chabner, R Sponzo, S Hubbard, et al.
Pageof 22

Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Cancer Treatment Reports|October 1, 1980
Nephrotoxicity of cis-diamminedichloroplatinum(II) as measured by urinary beta-glucuronidaseJ A Kuhn, W P Argy, T A Rakowski, et al.
Cancer Treatment Reports|November 1, 1981
Phase II study of PCNU in colorectal carcinomaE P Mitchell, J Y Killen, F P Smith, et al.
Gynecologic Oncology|December 1, 1974
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideR C Young, G P Canellos, B A Chabner, et al.
Cancer Research|May 1, 1980
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracilB Ardalan, D A Cooney, H N Jayaram, et al.
Cancer|May 15, 1983
The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancerC Gisselbrecht, F P Smith, J S MacDonald, et al.
Cancer|October 1, 1980
A phase II study of chlorozotocin in metastatic malignant melanomaD F Hoth, P S Schein, S Winokur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracilP V Woolley, M J Ayoob, F P Smith, et al.
Annals of Internal Medicine|June 1, 1974
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studiesR L Edelson, C H Kirkpatrick, E M Shevach, et al.
Cancer Chemotherapy Reports|September 1, 1973
High-dose intermittent intravenous infusion of procarbazine (NSC-77213)B A Chabner, R Sponzo, S Hubbard, et al.
Pageof 22